Drugs sold in India, whether generic or branded, are
either scheduled or non-scheduled drugs as per the Drugs and Cosmetics Rules,
1945.
The prices of all scheduled drugs is capped. But, the
Drugs (Prices Control) Order, 2013 (DPCO 2013) allows 16% margin to the
retailer, as per para 19 of the DPCO, within the ceiling price fixed by the
government. The distributor generally has a 8% trade margin. They are not
permitted to increase the price more than 10% in a year.
This means that chemists can give concession up to 16% in
controlled drugs and up to 20% in unscheduled drugs. The distributor or the
company can directly give up to 30% discount. High cost products are marketed
directly by the companies. In most cancer products the hospitals make 30%
margins or more.
Non-scheduled drugs, on the other hand, are not under
price control. So, the pharmaceuticals are at liberty to decide the margin and
they may decide the MRP. They fix the MRP of these drugs in such a way that
there is generous amount of trade margin for wholesalers and retailers.
However, it is reported by the industry that as a norm rather than the law, the
retailer enjoys a trade margin of 20% and the distributor a trade margin of 10%
for non-scheduled drugs. This comprises 89% of the market of non-scheduled
medicines with 27321 products. So, only about 11% (5503 products) have a trade
margin of more than 30%. But, the government can and has been intervening
whenever the need arises to cap the prices of drugs when brought to its notice
under Para 19 of the DPCO.
Most disposables, reagents, devices, equipments are
unscheduled products with no price control.
Here are few related terms and their meaning.
Retail price of a drug: This is the
price at which a drug is sold to a consumer. The manufacturer is required
to print such a price on the label of the product. In case of controlled
formulations, the retail price is a price arrived at or fixed in accordance
with the provisions of DPCO, 1995.
Local taxes extra: This now means
GST.
Total amount required to be paid: Printed MRP
(Maximum Retail Price) plus GST. However, a medicine can be sold below
this price.
Loose medicines: If a retailer sells loose
quantity (unpacked), the price of such medicine should not exceed pro-rata
amount of the price printed on the label of the container, plus 5% thereof.
Price control: Only 74 out of about 500
commonly used bulk drugs are kept under statutory price control. All formulations
containing these bulk drugs either in a single or combination form fall under
price-controlled category. However, the prices of other drugs can be regulated,
if warranted in public interest.
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical
Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA
No comments:
Post a Comment